By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Therma Bright Inc.

Therma Bright Inc. (TBRIF)

OTC Market Data in USD, Fundamentals in CAD
$0.04
$0.00
+6.99%
Last Update: 2 Sept 2025, 17:10
$2.52M
Market Cap
-7.04
P/E Ratio (TTM)
Forward Dividend Yield
$0.04 - $0.51
52 Week Range

TBRIF Stock Price Chart

Explore Therma Bright Inc. interactive price chart. Choose custom timeframes to analyze TBRIF price movements and trends.

TBRIF Company Profile

Discover essential business fundamentals and corporate details for Therma Bright Inc. (TBRIF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

8 Jan 2021

Employees

CEO

Roberto Fia

Description

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.

TBRIF Financial Timeline

Browse a chronological timeline of Therma Bright Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 8 Jul 2025

Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Oct 2023

EPS came in at -$0.00 , while revenue for the quarter reached $6.59K .

TBRIF Stock Performance

Access detailed TBRIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run